| Item Type | Name |
|
Concept
|
Adjuvants, Immunologic
|
|
Concept
|
Adenocarcinoma
|
|
Concept
|
Age Factors
|
|
Concept
|
Alanine Transaminase
|
|
Concept
|
Acetylation
|
|
Concept
|
Anus Neoplasms
|
|
Concept
|
Fabry Disease
|
|
Concept
|
Antibodies, Viral
|
|
Concept
|
Aerospace Medicine
|
|
Concept
|
Transaminases
|
|
Concept
|
alpha 1-Antichymotrypsin
|
|
Concept
|
Antiemetics
|
|
Concept
|
Carbazoles
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Antimetabolites, Antineoplastic
|
|
Concept
|
Carcinoid Tumor
|
|
Concept
|
Carcinoma
|
|
Concept
|
Appendicitis
|
|
Concept
|
Anthropometry
|
|
Concept
|
Antibodies, Anti-Idiotypic
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Base Sequence
|
|
Concept
|
Benzamides
|
|
Concept
|
Cell Nucleus
|
|
Concept
|
Dermatology
|
|
Concept
|
Aspartate Aminotransferases
|
|
Concept
|
Bilirubin
|
|
Concept
|
Bicarbonates
|
|
Concept
|
Flavonoids
|
|
Concept
|
Colonic Neoplasms
|
|
Concept
|
Chicago
|
|
Concept
|
Gastrointestinal Neoplasms
|
|
Concept
|
Leucovorin
|
|
Concept
|
Cortisone
|
|
Concept
|
Hematocrit
|
|
Concept
|
Hemoglobins
|
|
Concept
|
Dermatologic Agents
|
|
Concept
|
Diagnostic Errors
|
|
Concept
|
Dinitrobenzenes
|
|
Concept
|
Dexamethasone
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Immunosuppressive Agents
|
|
Concept
|
Insulin
|
|
Concept
|
Cytidine Deaminase
|
|
Concept
|
Documentation
|
|
Concept
|
Cyclophosphamide
|
|
Concept
|
Tegafur
|
|
Concept
|
Glucocorticoids
|
|
Concept
|
Glycoproteins
|
|
Concept
|
Hepatic Encephalopathy
|
|
Concept
|
Lung Volume Measurements
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Mass Screening
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Doxycycline
|
|
Concept
|
Fishes
|
|
Concept
|
Indoles
|
|
Concept
|
Interferons
|
|
Concept
|
Education, Nursing, Continuing
|
|
Concept
|
Electrocardiography
|
|
Concept
|
Fluorouracil
|
|
Concept
|
Gelatin
|
|
Concept
|
Esophagogastric Junction
|
|
Concept
|
Glycolipids
|
|
Concept
|
Giant Cell Tumors
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Fibronectins
|
|
Concept
|
Kidney Diseases
|
|
Concept
|
Knee
|
|
Concept
|
Electrophoresis, Paper
|
|
Concept
|
Hypoglycemic Agents
|
|
Concept
|
Liposomes
|
|
Concept
|
Immunotherapy
|
|
Concept
|
Insulin-Like Growth Factor I
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Hospital Information Systems
|
|
Concept
|
Exchange Transfusion, Whole Blood
|
|
Concept
|
Hydrocortisone
|
|
Concept
|
Flatfoot
|
|
Concept
|
Immunity, Cellular
|
|
Concept
|
Germ Cells
|
|
Concept
|
Leucine
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Haptens
|
|
Concept
|
Management Information Systems
|
|
Concept
|
Carcinoma, Hepatocellular
|
|
Concept
|
Maytansine
|
|
Concept
|
Metformin
|
|
Concept
|
Mice, Inbred Strains
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Liver Function Tests
|
|
Concept
|
Platelet-Derived Growth Factor
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Indazoles
|
|
Concept
|
Organ Size
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Glycolysis
|
|
Concept
|
Pain
|
|
Concept
|
Palliative Care
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
Mesothelioma
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Hepatic Artery
|
|
Concept
|
Genes, Intracisternal A-Particle
|
|
Concept
|
Kidney Function Tests
|
|
Concept
|
Knee Joint
|
|
Concept
|
L-Lactate Dehydrogenase
|
|
Concept
|
Peritoneum
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Ligands
|
|
Concept
|
Lymphokines
|
|
Concept
|
Paronychia
|
|
Concept
|
Pheochromocytoma
|
|
Concept
|
Phenylurea Compounds
|
|
Concept
|
Preoperative Care
|
|
Concept
|
Prostatic Neoplasms
|
|
Concept
|
Gallbladder Neoplasms
|
|
Concept
|
Gamma Rays
|
|
Concept
|
Hyperinsulinism
|
|
Concept
|
Glutamates
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Radiation Injuries
|
|
Concept
|
Guanine
|
|
Concept
|
Registries
|
|
Concept
|
Risk Factors
|
|
Concept
|
Quality of Life
|
|
Concept
|
Vitamin B 12
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Relaxation
|
|
Concept
|
Stomatitis
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Sweetening Agents
|
|
Concept
|
Heparin
|
|
Concept
|
Histones
|
|
Concept
|
Humans
|
|
Concept
|
Listeria monocytogenes
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Incidence
|
|
Concept
|
Endothelial Growth Factors
|
|
Concept
|
Tritium
|
|
Concept
|
Medical Records Systems, Computerized
|
|
Concept
|
Hepatocyte Growth Factor
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Vaccination
|
|
Concept
|
Multicenter Studies as Topic
|
|
Concept
|
Geriatric Assessment
|
|
Concept
|
Total Lung Capacity
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Macrophage Colony-Stimulating Factor
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Nutrition Policy
|
|
Concept
|
Cell Culture Techniques
|
|
Concept
|
Radiopharmaceuticals
|
|
Concept
|
Genes, BRCA2
|
|
Concept
|
Global Health
|
|
Concept
|
Prevalence
|
|
Concept
|
DNA, Antisense
|
|
Concept
|
Metabolic Clearance Rate
|
|
Concept
|
Exercise
|
|
Concept
|
Fatty Acids, Omega-3
|
|
Concept
|
Observer Variation
|
|
Concept
|
Mitochondria
|
|
Concept
|
Paclitaxel
|
|
Concept
|
Empyema, Pleural
|
|
Concept
|
Comorbidity
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Receptor, IGF Type 1
|
|
Concept
|
Medical Oncology
|
|
Concept
|
Melanoma
|
|
Concept
|
Microtubules
|
|
Concept
|
National Institutes of Health (U.S.)
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Angiopoietin-2
|
|
Concept
|
Nutritive Value
|
|
Concept
|
Antigen Presentation
|
|
Concept
|
Antibodies, Bispecific
|
|
Concept
|
Cholangiocarcinoma
|
|
Concept
|
Efficiency, Organizational
|
|
Concept
|
Receptors, Growth Factor
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Patient-Centered Care
|
|
Concept
|
ras Proteins
|
|
Concept
|
Databases as Topic
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Dietary Sucrose
|
|
Concept
|
Kv1.3 Potassium Channel
|
|
Concept
|
cdc25 Phosphatases
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Chemokine CXCL12
|
|
Concept
|
Cone-Beam Computed Tomography
|
|
Concept
|
Insulin-Like Growth Factor Binding Protein 3
|
|
Concept
|
In Situ Hybridization, Fluorescence
|
|
Concept
|
Marital Status
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Consensus
|
|
Concept
|
Incidental Findings
|
|
Concept
|
Vascular Endothelial Growth Factors
|
|
Concept
|
Receptor, Fibroblast Growth Factor, Type 1
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Chromatin Immunoprecipitation
|
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
|
Concept
|
Carcinoma, Small Cell
|
|
Concept
|
Proto-Oncogene Proteins c-raf
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p16
|
|
Concept
|
Amino Acid Substitution
|
|
Concept
|
Cell Growth Processes
|
|
Concept
|
Proto-Oncogene Proteins c-kit
|
|
Concept
|
Receptor, Platelet-Derived Growth Factor alpha
|
|
Concept
|
Evidence-Based Medicine
|
|
Concept
|
Genes, BRCA1
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
Phorbol Esters
|
|
Concept
|
Polyethylene Glycols
|
|
Concept
|
Postoperative Care
|
|
Concept
|
Focal Adhesion Kinase 1
|
|
Concept
|
Mucositis
|
|
Concept
|
Hedgehog Proteins
|
|
Concept
|
National Cancer Institute (U.S.)
|
|
Concept
|
Sarcoma
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Stomach Neoplasms
|
|
Concept
|
Taxoids
|
|
Concept
|
Gastrointestinal Stromal Tumors
|
|
Concept
|
Class I Phosphatidylinositol 3-Kinases
|
|
Concept
|
TOR Serine-Threonine Kinases
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Sex Factors
|
|
Concept
|
Osteopontin
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Sulfobromophthalein
|
|
Concept
|
Immunoblotting
|
|
Concept
|
Colorectal Neoplasms
|
|
Concept
|
Epithelioid Cells
|
|
Concept
|
Diet Records
|
|
Concept
|
PTEN Phosphohydrolase
|
|
Concept
|
Meta-Analysis as Topic
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Patient Satisfaction
|
|
Concept
|
Genetic Therapy
|
|
Concept
|
Survival Rate
|
|
Concept
|
Granisetron
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
Receptor, ErbB-2
|
|
Concept
|
Insulin-Like Growth Factor Binding Protein 2
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Karnofsky Performance Status
|
|
Concept
|
Proto-Oncogene Proteins c-met
|
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
|
Concept
|
Interleukin-17
|
|
Concept
|
Carcinoma, Pancreatic Ductal
|
|
Concept
|
Imaging, Three-Dimensional
|
|
Concept
|
SEER Program
|
|
Concept
|
Gadolinium DTPA
|
|
Concept
|
Receptor, trkA
|
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Precision Medicine
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
alpha-Galactosidase
|
|
Concept
|
Immunotoxins
|
|
Concept
|
Benzenesulfonates
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Drug Eruptions
|
|
Concept
|
DNA Helicases
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Empyema
|
|
Concept
|
Epidermal Growth Factor
|
|
Concept
|
Esophageal Neoplasms
|
|
Concept
|
Folic Acid
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Genetic Counseling
|
|
Concept
|
Genetic Testing
|
|
Concept
|
Health Status
|
|
Concept
|
Learning
|
|
Concept
|
Lysine
|
|
Concept
|
Oligonucleotides
|
|
Concept
|
Osteomyelitis
|
|
Concept
|
Oxides
|
|
Concept
|
Patient Compliance
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Histone-Lysine N-Methyltransferase
|
|
Concept
|
Purine-Nucleoside Phosphorylase
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Glucuronosyltransferase
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Concept
|
Cytokines
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Fibroblast Growth Factor 2
|
|
Concept
|
Information Storage and Retrieval
|
|
Concept
|
Oligonucleotides, Antisense
|
|
Concept
|
Mitomycin
|
|
Concept
|
Neuroendocrine Tumors
|
|
Concept
|
Point-of-Care Systems
|
|
Concept
|
Vascular Endothelial Growth Factor D
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Focal Adhesion Kinase 2
|
|
Concept
|
GPI-Linked Proteins
|
|
Academic Article
|
Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase.
|
|
Academic Article
|
Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer.
|
|
Academic Article
|
Metastatic colorectal cancer.
|
|
Academic Article
|
Pemetrexed in pancreatic cancer.
|
|
Academic Article
|
Pemetrexed in patients with gastrointestinal carcinoma.
|
|
Academic Article
|
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).
|
|
Academic Article
|
A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumors.
|
|
Academic Article
|
Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies.
|
|
Academic Article
|
Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma.
|
|
Academic Article
|
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.
|
|
Academic Article
|
Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers.
|
|
Academic Article
|
In focus: advanced pancreatic cancer.
|
|
Academic Article
|
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.
|
|
Academic Article
|
Current state and future directions of pleural mesothelioma imaging.
|
|
Academic Article
|
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study.
|
|
Academic Article
|
Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.
|
|
Academic Article
|
The emerging role of pemetrexed for the treatment of malignant mesothelioma.
|
|
Academic Article
|
Antiangiogenic therapies for mesothelioma.
|
|
Academic Article
|
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
|
|
Academic Article
|
Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
|
|
Academic Article
|
A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours.
|
|
Academic Article
|
Computerized segmentation and measurement of malignant pleural mesothelioma.
|
|
Academic Article
|
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).
|
|
Academic Article
|
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
|
|
Academic Article
|
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
|
|
Academic Article
|
GAMES II Project: a general architecture for medical knowledge-based systems.
|
|
Academic Article
|
[Autoradiographic studies on tissue protein metabolism in wound healing].
|
|
Academic Article
|
[Treatment of severe forms of hematogenous osteomyelitis with special reference to protein metabolism].
|
|
Academic Article
|
Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitor.
|
|
Academic Article
|
[Learning and teaching].
|
|
Academic Article
|
Save medical personnel's time by improved user interfaces.
|
|
Academic Article
|
[COMPARISON OF PROTEIN METABOLISM BETWEEN FIBROCYTES AND ACTIVATED FIBROBLASTS. (AUTORADIOGRAPHIC STUDIES WITH H3-LEUCINE)].
|
|
Academic Article
|
Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.
|
|
Academic Article
|
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.
|
|
Academic Article
|
Variability of tumor area measurements for response assessment in malignant pleural mesothelioma.
|
|
Academic Article
|
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
|
|
Academic Article
|
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.
|
|
Academic Article
|
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.
|
|
Academic Article
|
Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
|
|
Academic Article
|
Child Abuse and Neglect: Screening for Risks During the Perinatal Period.
|
|
Academic Article
|
Preliminary activity of XL880, a dual MET/VEGFR2 inhibitor, in MET amplified poorly differentiated gastric cancer (PDGC): Interim results of a multicenter phase II study.
|
|
Academic Article
|
Final analysis of a randomized phase II study of bevacizumab (B) and gemcitabine (G) plus cetuximab (C) or erlotinib (E) in patients (pts) with advanced pancreatic cancer (PC).
|
|
Academic Article
|
Influence of Pleurectomy and Decortication in Health-Related Quality of Life Among Patients with Malignant Pleural Mesothelioma.
|
|
Academic Article
|
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
|
|
Academic Article
|
Marine ?-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance).
|
|
Academic Article
|
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma.
|
|
Academic Article
|
Perioperative Gemcitabine?+?Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial.
|
|
Academic Article
|
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma.
|
|
Academic Article
|
EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.
|
|
Academic Article
|
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
|
|
Academic Article
|
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors.
|
|
Academic Article
|
Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance).
|
|
Academic Article
|
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
|
|
Academic Article
|
Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
|
|
Academic Article
|
The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.
|
|
Academic Article
|
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
|
|
Academic Article
|
A population-based evaluation of tunica vaginalis mesothelioma: An analysis of the National Cancer Database.
|
|
Concept
|
Pemetrexed
|
|
Concept
|
Bevacizumab
|
|
Concept
|
Imatinib Mesylate
|
|
Concept
|
Cetuximab
|
|
Concept
|
Capecitabine
|
|
Concept
|
Filgrastim
|
|
Concept
|
Bortezomib
|
|
Concept
|
Positron Emission Tomography Computed Tomography
|
|
Concept
|
Protein Kinase C beta
|
|
Concept
|
Neurokinin-1 Receptor Antagonists
|
|
Concept
|
Protective Factors
|
|
Concept
|
ErbB Receptors
|
|
Concept
|
Lipid Droplets
|
|
Grant
|
Novel Targeted Therapy in Pancreatic Cancer
|
|
Academic Article
|
Mesothelioma in situ of the peritoneum: report of three cases and review of the literature.
|